4.7 Article

QSAR-based permeability model for drug-like compounds

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 19, 期 8, 页码 2615-2624

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2011.03.011

关键词

Chemical space; Computational chemistry; Drug discovery; Quantitative structure-activity relationships (QSAR); Permeability

资金

  1. Spanish Ministerio de Ciencia e Innovacion (MCINN) [SAF2008-01845]

向作者/读者索取更多资源

A QSAR model was developed for predicting intestinal drug permeability, one of the most important parameters when evaluating compounds in drug discovery projects. First, a set of relevant properties for establishing a drug-like chemical space was applied to a database of compounds with Caco-2 permeability values obtained from previous studies. Several QSAR regression models were then developed from this set of drug-like structures. The best model was selected based on the accuracy of correct classifications obtained for training and validation subsets previously defined, including 17 structures from the FDA Biopharmaceutics Classification System (BCS). Further validation of the QSAR model was performed by applying it to 21 drugs for which Caco-2 permeability values were experimentally determined by us. The good agreement between predictions and experimental values in all cases confirmed the reliability of the equation. Since the model was developed with very simple descriptors, easy to calculate, its applicability to large collections of in silico chemicals is guaranteed. (C) 2011 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making

Jan L. Brozek, Carlos Canelo-Aybar, Elie A. Akl, James M. Bowen, John Bucher, Weihsueh A. Chiu, Mark Cronin, Benjamin Djulbegovic, Maicon Falavigna, Gordon H. Guyatt, Ami A. Gordon, Michele Hilton Boon, Raymond C. W. Hutubessy, Manuela A. Joore, Vittal Katikireddi, Judy LaKind, Miranda Langendam, Veena Manja, Kristen Magnuson, Alexander G. Mathioudakis, Joerg Meerpohl, Dominik Mertz, Roman Mezencev, Rebecca Morgan, Gian Paolo Morgano, Reem Mustafa, Martin O'Flaherty, Grace Patlewicz, John J. Riva, Margarita Posso, Andrew Rooney, Paul M. Schlosser, Lisa Schwartz, Ian Shemilt, Jean-Eric Tarride, Kristina A. Thayer, Katya Tsaioun, Luke Vale, John Wambaugh, Jessica Wignall, Ashley Williams, Feng Xie, Yuan Zhang, Holger J. Schunemann

Summary: This study presents a conceptual approach for evaluating the certainty of evidence from modeling studies using the GRADE method. The results indicate that the domains determining the certainty of evidence also apply to assessing evidence from models. A framework for selecting the best evidence from models and a summary of preferred terminology are proposed to facilitate communication between modeling and health care disciplines.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Article Rheumatology

The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis

Alejandro Artacho, Sandrine Isaac, Renuka Nayak, Alejandra Flor-Duro, Margaret Alexander, Imhoi Koo, Julia Manasson, Philip B. Smith, Pamela Rosenthal, Yamen Homsi, Percio Gulko, Javier Pons, Leonor Puchades-Carrasco, Peter Izmirly, Andrew Patterson, Steven B. Abramson, Antonio Pineda-Lucena, Peter J. Turnbaugh, Carles Ubeda, Jose U. Scher

Summary: This study investigated the potential of the human gut microbiome in predicting methotrexate (MTX) efficacy in new-onset rheumatoid arthritis (RA) patients. The analysis revealed significant associations between gut bacterial taxa abundance and genes with future clinical response, as well as a microbiome-based model that predicted lack of response to MTX. Ex vivo experiments also suggested a possible direct effect of the gut microbiome on MTX metabolism and treatment outcomes, supporting the value of the gut microbiome as a potential prognostic tool and therapeutic target in RA.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Oncology

Polycythemia Vera and Essential Thrombocythemia Patients Exhibit Unique Serum Metabolic Profiles Compared to Healthy Individuals and Secondary Thrombocytosis Patients

Nuria Gomez-Cebrian, Ayelen Rojas-Benedicto, Arturo Albors-Vaquer, Beatriz Bellosillo, Carlos Besses, Joaquin Martinez-Lopez, Antonio Pineda-Lucena, Leonor Puchades-Carrasco

Summary: The diagnosis of myeloproliferative neoplasms (MPNs) is controversial due to limitations in reproducibility and subjectivity, along with common somatic mutations in driver genes. Metabolomics was utilized to characterize serum metabolic profiles of MPNs patients (PV and ET) compared to healthy controls (HC) and secondary thrombocytosis (ST). Significant metabolic differences were found between PV and ET patients compared to HC and ST, suggesting the potential of metabolomics for disease differentiation.

CANCERS (2021)

Article Cell Biology

Metabolic footprint of aging and obesity in red blood cells

Ines Domingo-Orti, Ruben Lamas-Domingo, Andreea Ciudin, Cristina Hernandez, Jose Raul Herance, Martina Palomino-Schatzlein, Antonio Pineda-Lucena

Summary: Aging is a complex physiological process with crucial biochemical transformations. This study found metabolic alterations in red blood cells during aging, influenced by both obesity and age. The metabolomics profile of red blood cells was also impacted by obesity, sometimes mirroring and other times contrasting with the changes induced by aging.

AGING-US (2021)

Article Chemistry, Medicinal

Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma

Obdulia Rabal, Edurne San Jose-Eneriz, Xabier Agirre, Juan Antonio Sanchez-Arias, Irene de Miguel, Raquel Ordonez, Leire Garate, Estibaliz Miranda, Elena Saez, Amaia Vilas-Zornoza, Antonio Pineda-Lucena, Ander Estella, Feifei Zhang, Wei Wu, Musheng Xu, Felipe Prosper, Julen Oyarzabal

Summary: The study reports a first-in-class series of quinoline-based analogues that simultaneously inhibit histone deacetylases, DNA methyltransferase-1, and lysine methyltransferase G9a. These multitarget epigenetic inhibitors show promising in vitro and in vivo antitumor efficacy against multiple myeloma.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor

Teresa Lozano, Noelia Casares, Celia Martil-Otal, Blanca Anega, Marta Gorraiz, Jonathan Parker, Marta Ruiz, Virginia Belsue, Antonio Pineda-Lucena, Julen Oyarzabal, Juan Jose Lasarte

Summary: The study demonstrates the potential therapeutic impact of using synthetic peptides to disrupt Foxp3 protein-protein interactions in affecting Treg cell functionality in cancer treatment.

BIOMEDICINES (2021)

Article Multidisciplinary Sciences

A surface plasmon resonance based approach for measuring response to pneumococcal vaccine

Marta Garrido-Jareno, Leonor Puchades-Carrasco, Leticia Orti-Perez, Jose Miguel Sahuquillo-Arce, Maria del Carmen Meyer-Garcia, Joan Mollar-Maseres, Carmina Lloret-Sos, Ana Gil-Brusola, Jose Luis Lopez-Hontangas, Jose Manuel Beltran-Garrido, Javier Peman-Garcia, Antonio Pineda-Lucena

Summary: This study aims to evaluate the reliability of using SPR technology for quantifying anti-pneumococcal capsular polysaccharides (anti-PnPs) IgGs in vaccinated individuals.

SCIENTIFIC REPORTS (2021)

Article Allergy

Characterization of anaphylaxis reveals different metabolic changes depending on severity and triggers

Carolina Perales-Chorda, David Obeso, Laura Twomey, Ayelen Rojas-Benedicto, Leonor Puchades-Carrasco, Marta Roca, Antonio Pineda-Lucena, Jose Julio Laguna, Coral Barbas, Vanesa Esteban, Jaume Marti-Garrido, Ethel Ibanez-Echevarria, Ramon Lopez-Salgueiro, Domingo Barber, Alma Villasenor, Dolores Hernandez Fernandez de Rojas

Summary: This study aimed to explore metabolic changes in patients suffering from anaphylactic reactions based on triggers (food and/or drug) and severity (moderate and severe). Results indicate that different triggers or severity levels can induce differential metabolic changes at different time points, offering new insights into understanding, diagnosing, and treating anaphylaxis.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Article Gastroenterology & Hepatology

Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage

Maria Garate-Rascon, Miriam Recalde, Maddalen Jimenez, Maria Elizalde, Maria Azkona, Iker Uriarte, M. Uxue Latasa, Raquel Urtasun, Idoia Bilbao, Bruno Sangro, Carmen Garcia-Ruiz, Jose C. Fernandez-Checa, Fernando J. Corrales, Argitxu Esquivel, Antonio Pineda-Lucena, Maite G. Fernandez-Barrena, Matias A. Avila, Maria Arechederra, Carmen Berasain

Summary: SLU7 plays a crucial role in maintaining hepatocellular identity and protecting against liver disease progression, by preserving the stability of HNF4 alpha 1 protein through its protective function against oxidative stress, thus preventing hepatocellular dedifferentiation.

HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort

R. Conde, R. Laires, L. G. Goncalves, A. Rizvi, C. Barroso, M. Villar, R. Macedo, M. J. Simoes, S. Gaddam, P. Lamosa, L. Puchades-Carrasco, A. Pineda-Lucena, A. B. Patel, S. C. Mande, S. Banerjee, M. Matzapetakis, A. Coelho

Summary: This study utilized Nuclear Magnetic Resonance based metabolomics to discover a signature of biomarkers for tuberculosis diagnosis. Six metabolites associated with TB infection were validated, in line with the recommendations of the World Health Organization.

BIOMEDICAL JOURNAL (2022)

Article Oncology

Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer

Borja Ruiz-Fernandez de Cordoba, Haritz Moreno, Karmele Valencia, Naiara Perurena, Pablo Ruedas, Thomas Walle, Alberto Pezonaga-Torres, Juan Hinojosa, Elisabet Guruceaga, Antonio Pineda-Lucena, Marta Abengozar-Muela, Denis Cochonneau, Carolina Zandueta, Susana Martinez-Canarias, Alvaro Teijeira, Daniel Ajona, Sergio Ortiz-Espinosa, Xabier Morales, Carlos Ortiz de Solorzano, Marta Santisteban, Luis Ramos-Garcia, Laura Guembe, Vratislav Strnad, Dominique Heymann, Sandra Hervas-Stubbs, Ruben Pio, Maria E. Rodriguez-Ruiz, Carlos E. de Andrea, Silvestre Vicent, Ignacio Melero, Fernando Lecanda, Rafael Martinez-Monge

Summary: Locoregional failure in breast cancer patients after surgery and irradiation is linked to a poor prognosis. The ENPP1/HP axis is exploited by tumor cells to promote local recurrence by suppressing immune cells. Blocking this axis offers new opportunities for therapeutic intervention.

CANCER DISCOVERY (2022)

Review Oncology

Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches

Nuria Gomez-Cebrian, Jose Luis Poveda, Antonio Pineda-Lucena, Leonor Puchades-Carrasco

Summary: Prostate cancer is a heterogeneous tumor with a highly variable clinical outcome. Integrating multi-omics datasets can be a powerful approach for developing novel metabolic signatures to improve the clinical management of prostate cancer patients.

CANCERS (2022)

Article Cell Biology

Metabolic Alterations in a Drosophila Model of Parkinson's Disease Based on DJ-1 Deficiency

Cristina Solana-Manrique, Francisco Jose Sanz, Isabel Torregrosa, Martina Palomino-Schatzlein, Carolina Hernandez-Oliver, Antonio Pineda-Lucena, Nuria Paricio

Summary: The study investigates metabolic disturbances underlying the pathogenesis of Parkinson's disease (PD) using a Drosophila PD model. Through metabolomic analysis, the study finds that metabolic alterations are associated with PD and could potentially serve as therapeutic targets and biomarkers for the disease.
Review Chemistry, Medicinal

Pharmacometabolomics by NMR in Oncology: A Systematic Review

Nuria Gomez-Cebrian, Pedro Vazquez Ferreiro, Francisco Javier Carrera Hueso, Jose Luis Poveda Andres, Leonor Puchades-Carrasco, Antonio Pineda-Lucena

Summary: Pharmacometabolomics studies focus on predicting individual responses and adverse reactions to drug treatments by analyzing metabolic profiles, which can guide patient selection in clinical trials to enhance drug efficacy and safety. This approach, closely linked to phenotype, provides valuable insights into specific metabolic changes associated with therapeutic interventions.

PHARMACEUTICALS (2021)

Review Veterinary Sciences

Reviewing the animal literature: how to describe and choose between different types of literature reviews

Cathalijn Leenaars, Katya Tsaioun, Frans Stafleu, Kieron Rooney, Franck Meijboom, Merel Ritskes-Hoitinga, Andre Bleich

Summary: Before embarking on an animal research project, conducting a thorough literature review is essential to avoid redundancy, improve research reliability, and address research questions effectively. Understanding the various types of literature reviews and their associated terminology can help clarify conclusions and prevent ambiguity in research interpretation.

LABORATORY ANIMALS (2021)

暂无数据